drugIndia
Cart
Already at best price
Ecoglip-TM Tablet PR

Ecoglip-TM Tablet PR

Metformin (500mg) + Teneligliptin (20mg)

Ozone Pharmaceuticals Ltd
Anti-Diabetic
37.5046.8820% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
37.5020% OFF
46.88

About This Medicine

Product description & overview

Ecoglip-TM Tablet PR is a combination anti-diabetic medication containing Metformin 500mg and Teneligliptin 20mg, formulated to help manage blood sugar levels in individuals with type 2 diabetes. Metformin works by reducing glucose production in the liver and improving the body’s sensitivity to insulin, while Teneligliptin increases incretin hormone activity to enhance insulin secretion after meals. Together, these ingredients provide effective and balanced blood sugar control throughout the day. The prolonged-release formulation helps maintain stable glucose levels and supports better metabolic control. When used alongside a healthy diet and regular physical activity, Ecoglip-TM Tablet PR helps reduce the risk of diabetes-related complications such as nerve damage, kidney problems, and heart disease when taken as directed by a healthcare professional.

Active composition

Metformin 500 mg

+1 more active ingredient

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Teneligliptin20 mg

Teneligliptin

Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

Ecoglip-TM Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

High Risk

Pregnancy

Ecoglip-TM Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Medical Advice

Driving

Ecoglip-TM Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Ecoglip-TM Tablet PR may be needed. Please consult your doctor. Use of Ecoglip-TM Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Exercise Caution

Breastfeeding

It is not known whether Ecoglip-TM Tablet PR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Consult Doctor

Kidney

Ecoglip-TM Tablet PR is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.

Regular Checkup

Customer Reviews

0 reviews for Ecoglip-TM Tablet PR

Products matching your search